NCT04761783View on ClinicalTrials.gov

BESPOKE Study of ctDNA Guided Immunotherapy

CompletedOBSERVATIONAL
Enrollment

290

Participants

Timeline

Start Date

May 28, 2021

Primary Completion Date

December 31, 2023

Study Completion Date

March 30, 2024

Conditions
Colorectal CancerMelanomaNon-small Cell Lung Cancer
Trial Locations (1)

94070

Natera, San Carlos

Sponsors

Lead Sponsor

Natera, Inc.
All Listed Sponsors
lead

Natera, Inc.

INDUSTRY

NCT04761783 - BESPOKE Study of ctDNA Guided Immunotherapy | Biotech Hunter | Biotech Hunter